Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort

•Hepatic injury markers declined over 2 years after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV.•Reduction was stronger in patients with hepatitis B surface antigen+ and those with baseline chronic enzyme elevation.•Lipid parameters increased mainly in th...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of infectious diseases Ročník 161; s. 108081
Hlavní autoři:	Poliseno, Mariacristina, Caputo, Sergio Lo, Tavelli, Alessandro, Gagliardini, Roberta, Gazzola, Lidia, Saracino, Annalisa, Santantonio, Teresa Antonia, Squillace, Nicola, Puoti, Massimo, Mazzotta, Valentina, Antinori, Adndrea, d’Arminio Monforte, Antonella, Cozzi-Lepri, Alessandro
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Canada Elsevier Ltd 01.12.2025 Elsevier
Témata:	Adenine - analogs & derivatives Adenine - therapeutic use Adult Alanine Alanine Transaminase - blood ALT Anti-HIV Agents - therapeutic use Biomarkers - blood Cholesterol Cohort Studies Coinfection - drug therapy Drug Substitution Female Hepatitis B - complications Hepatitis B - drug therapy HIV Infections - complications HIV Infections - drug therapy HIV Infections - metabolism HIV/HBV coinfection Humans Infectious Disease Liver - drug effects Liver - metabolism Male Middle Aged Pulmonary/Respiratory Tenofovir - analogs & derivatives Tenofovir - therapeutic use Tenofovir alafenamide Tenofovir disoproxil fumarate ALT HIV/HBV coinfection Tenofovir alafenamide Tenofovir disoproxil fumarate Cholesterol
ISSN:	1201-9712, 1878-3511
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!